CD276 and osteosarcoma: Interestingly, the rapid-clearing osteosarcoma model exhibited a small increase in neurogenesis following tumor-clearing B7H3-CAR T cell administration, but was at control levels following tumor-clearing GD2-CAR T cell administration (Figure 5D).